Antisense oligonucleotide therapy reduces seizures and extends life span in an SCN2A gain-of-function epilepsy model
Author:
Funder
National Health and Medical Research Council
RogCon Biosciences
Publisher
American Society for Clinical Investigation
Subject
General Medicine
Link
https://www.jci.org/articles/view/152079/files/pdf
Reference42 articles.
1. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology
2. Models for discovery of targeted therapy in genetic epileptic encephalopathies
3. Channelopathies as a genetic cause of epilepsy
4. Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies
5. FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Developmental and epileptic encephalopathies;Nature Reviews Disease Primers;2024-09-05
2. Memory inflation: Beyond the acute phase of viral infection;Cell Proliferation;2024-07-11
3. The contribution of NaV1.6 to the efficacy of voltage‐gated sodium channel inhibitors in wild type and NaV1.6 gain‐of‐function (GOF) mouse seizure control;British Journal of Pharmacology;2024-06-24
4. Protocol for inducing severe Scn2a insufficiency in mice by intracerebroventricular antisense oligonucleotide injection;STAR Protocols;2024-06
5. Molecular Insights of Drug Resistance in Epilepsy: Multi-omics Unveil;Molecular Neurobiology;2024-05-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3